Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34+ cells in NOD/SCID mice

Experimental Hematology

Volumn 31, Issue 10, 2003, Pages 881-889

  In 't Anker, Pieternella S ^a   Noort, Willy A ^a   Kruisselbrink, Alwine B ^a   Scherjon, Sicco A ^a   Beekhuizen, Willem ^b   Willemze, Roelof ^a   Kanhai, Humphrey H H ^a   Fibbe, Willem E ^a,c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Center of Human Reproduction   (Netherlands)

^c C2R ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

ANIMAL CELL; ARTICLE; BONE MARROW; CELL CULTURE; CONTROLLED STUDY; FEMALE; FETUS; FETUS LIVER; FETUS LUNG; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MESENCHYME CELL; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SPLEEN; UMBILICAL CORD BLOOD;

EID: 0141484486     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(03)00202-9     Document Type: Article

References (37)

1. Broxmeyer H.E., Douglas G.W., Hangoc G., et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A. 86:1989;3828-3832.
2. Gluckman E., Broxmeyer H.A., Auerbach A.D., et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med. 321:1989;1174-1178.
3. Wagner J.E., Rosenthal J., Sweetman R., et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-vs-host disease. Blood. 88:1996;795-802.
4. Kurtzberg J., Laughlin M., Graham M.L., et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med. 335:1996;157-166.
5. Cairo M.S., Wagner J.E. Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. Blood. 90:1997;4665-4678.
6. Laughlin M.J., Barker J., Bambach B., et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med. 344:2001;1815-1822.
7. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science. 284:1999;143-147.
8. Bianco P., Gehron R.P. Marrow stromal stem cells. J Clin Invest. 105:2000;1663-1668.
9. Deans R.J., Moseley A.B. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol. 28:2000;875-884.
10. Caplan A.I. The mesengenic process. Clin Plast Surg. 21:1994;429-435.
11. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 276:1997;71-74.
12. Allen T.D., Dexter T.M., Simmons P.J. Marrow biology and stem cells. Immunol Ser. 49:1990;1-38.
13. Simmons P.J., Zannettino A., Gronthos S., Leavesley D. Potential adhesion mechanisms for localisation of haemopoietic progenitors to bone marrow stroma. Leuk Lymphoma. 12:1994;353-363.
14. Lichtman M.A. The ultrastructure of the hemopoietic environment of the marrow: a review. Exp Hematol. 9:1981;391-410.
15. Dexter T.M., Coutinho L.H., Spooncer E., et al. Stromal cells in haemopoiesis. Ciba Found Symp. 148:1990;76-86.
16. Piersma A.H., Ploemacher R.E., Brockbank K.G. Radiation damage to femoral hemopoietic stroma measured by implant regeneration and quantitation of fibroblastic progenitors. Exp Hematol. 11:1983;884-890.
17. Galotto M., Berisso G., Delfino L., et al. Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients. Exp Hematol. 27:1999;1460-1466.
18. Fried W., Barone J. Residual marrow damage following therapy with cyclophosphamide. Exp Hematol. 8:1980;610-614.
19. Simmons P.J., Przepiorka D., Thomas E.D., Torok-Storb B. Host origin of marrow stromal cells following allogeneic bone marrow transplantation. Nature. 328:1987;429-432.
20. Erices A., Conget P., Minguell J.J. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 109:2000;235-242.
21. Campagnoli C., Roberts I.A., Kumar S., Bennett P.R., Bellantuono I., Fisk N.M. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood. 98:2001;2396-2402.
22. Mareschi K., Biasin E., Piacibello W., Aglietta M., Madon E., Fagioli F. Isolation of human mesenchymal stem cells: bone marrow vs umbilical cord blood. Haematologica. 86:2001;1099-1100.
23. + cells in NOD/SCID mice. Exp Hematol. 30:2002;870-878.
24. Almeida-Porada G., Porada C.D., Tran N., Zanjani E.D. Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation. Blood. 95:2000;3620-3627.
25. Almeida-Porada G., Flake A.W., Glimp H.A., Zanjani E.D. Cotransplantation of stroma results in enhancement of engraftment and early expression of donor hematopoietic stem cells in utero. Exp Hematol. 27:1999;1569-1575.
26. Frassoni F., Labopin M., Bacigalupo A. Expanded mesenchymal stem cells (MSC), co-infused with HLA identical hemopoietic stem cell transplants, reduce acute and chronic graft vs host disease: a matched pair analysis. [abstract] Bone Marrow Transplant. 29:(suppl):2002.
27. Miltenyi S., Muller W., Weichel W., Radbruch A. High gradient magnetic cell separation with MACS. Cytometry. 11:1990;231-238.
28. van de Corput L., Kluin-Nelemans H.C., Kester M.G., Willemze R., Falkenburg J.H. Hairy cell leukemia-specific recognition by multiple autologous HLA-DQ or DP-restricted T-cell clones. Blood. 93:1999;251-259.
29. in 't Anker P.S., Noort W.A., Scherjon S.A., et al. Characterization of mesenchymal stem cells in human second-trimester bone marrow, liver, lung and spleen. [abstract] Blood. 100:2002;523a.
30. Dennis J.E., Charbord P. Origin and differentiation of human and murine stroma. Stem Cells. 20:2002;205-214.
31. Waller E.K., Olweus J., Lund-Johansen F., et al. The "common stem cell" hypothesis reevaluated: human fetal bone marrow contains separate populations of hematopoietic and stromal progenitors. Blood. 85:1995;2422-2435.
32. Simmons P.J., Torok-Storb B. CD34 expression by stromal precursors in normal human adult bone marrow. Blood. 78:1991;2848-2853.
33. in 't Anker P.S., Noort W.A., Scherjon S.A., et al. Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica. 88:2003;845-852.
34. Rombouts W.J., Ploemacher R.E. Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia. 17:2003;160-170.
35. Bartholomew A., Sturgeon C., Siatskas M., et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol. 30:2002;42-48.
36. Di Nicola M., Carlo-Stella C., Magni M., et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood. 99:2002;3838-3843.
37. Kurosaka D., LeBien T.W., Pribyl J.A. Comparative studies of different stromal cell microenvironments in support of human B-cell development. Exp Hematol. 27:1999;1271-1281.